Recognizing At-Risk Patients and Managing CKD-Related Anemia CME

Author Information and Disclosures

Release Date: April 23, 2008; Valid for credit through April 23, 2009

Credits Available
Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Ortho Biotech
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Explain the importance of early recognition of chronic kidney disease (CKD) and CKD-related anemia
  2. Identify risk factors for anemia of CKD
  3. Determine appropriate early diagnostic testing for the evaluation of anemia in patients with CKD in the primary care setting
  4. Review guidelines for the diagnosis of early-stage CKD and anemia
  5. Clearly delineate the roles and responsibilities of the PCP and nephrologist once a patient is referred
Authors and Disclosures

Steven Fishbane, MD
Disclosure: Steven Fishbane, MD, has disclosed that he owns stock, stock options, or bonds in Affymax. Dr. Fishbane has also disclosed that he has received grants for clinical research and served as an advisor or consultant to Roche, Amgen, and Affymax.


Robert Provenzano, MD, FACP
Disclosure: Robert Provenzano, MD, FACP, has disclosed that he has received grants for clinical research from OrthoBiotech, Roche, Advanced Magnetics Inc., and Amgen. Dr. Provenzano has also disclosed that he has received grants for educational activities from Roche.


William J. Bennett, MD
Disclosure: William J. Bennett, MD, has disclosed no relevant financial relationships.


Anne G. Le, PharmD, RPh
Disclosure: Anne G. Le, PharmD, RPh, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.